Winship Cancer Institute, Emory University, Atlanta, GA
Roshan Sudhir Prabhu , Minhee Won , Edward G. Shaw , Meihua Wang , David Brachman , Minesh P. Mehta
Observation (%) | RT (%) | RT + PCV (%) | |
---|---|---|---|
Significant MMSE decline | |||
Year 1 | 0 / 62 (0) | 5 / 74 (6.8) | 2 / 51 (3.9) |
Year 3 | 0 / 44 (0) | 1 / 48 (2.1) | 0 / 43 (0) |
Year 5 | 0 / 27 (0) | 0 / 22 (0) | 2 / 25 (8) |
No MMSE change | |||
Year 1 | 60 / 62 (96.8) | 66 / 74 (89.2) | 44 / 51 (86.3) |
Year 3 | 44 / 44 (100) | 45 / 48 (93.8) | 38 / 43 (88.4) |
Year 5 | 27 / 27 (100) | 21 / 22 (95.5) | 20 / 25 (80) |
Significant MMSE gain | |||
Year 1 | 2 / 62 (3.2) | 3 / 74 (4.1) | 5 / 51 (9.8) |
Year 3 | 0 / 44 (0) | 2 / 48 (4.2) | 5 / 43 (11.6) |
Year 5 | 0 / 27 (0) | 1 / 22 (4.5) | 3 / 25 (12) |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Kohei Shitara
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Ming Lei
2023 ASCO Annual Meeting
First Author: Yelena Y. Janjigian
2023 ASCO Gastrointestinal Cancers Symposium
First Author: Yelena Y. Janjigian